Your search for comorbidities returned 56 results

Implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators manufactured by St. Jude Medical may have batteries that will prematurely deplete.

Cardiac recovery was independently predicted by age, nonischemic cardiomyopathy, time from cardiac diagnosis, lack of ICD, serum creatinine levels, and LV end-diastolic dimensions.

Previously abandoned leads were associated with more complications from infection.

Obese patients were at increased risk of death compared with patients of normal weight.

Stroke/systemic embolism rates were comparable between patients with atrial fibrillation with or without heart failure.

The group who developed diabetes earlier had less favorable left ventricular ejection fraction, 4-chamber longitudinal peak strain, and circumferential peak strain.

No differences between monotherapy and multiple anthrombotic therapy in rates of stroke, MACE, or death.

Carbohydrate antigen 125 strategy significantly reduced death and acute heart failure readmissions.

Out 952 patients, 20 experienced sudden cardiac death/malignant ventricular arrhythmias within the first 6 months of the study enrollment.

In the 30 days following ablation, women had higher risk of developing complications, including vascular, hematoma or hemorrhage, and tamponade.